tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with Liver Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, SX; Huang, QP; Li, P; Qin, J; Wu, ZZ; Xiao, GH | 1 |
1 other study(ies) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and Liver Neoplasms
Article | Year |
---|---|
Inhibition of adhesion of hepatocellular carcinoma cells to basement membrane components by receptor competition with RGD- or YIGSR-containing synthetic peptides.
Topics: Basement Membrane; Binding, Competitive; Carcinoma, Hepatocellular; Cell Adhesion; Collagen Type IV; Dose-Response Relationship, Drug; Fibronectins; Humans; Laminin; Liver Neoplasms; Micromanipulation; Neoplasm Proteins; Oligopeptides; Tumor Cells, Cultured | 2003 |